MESO

MESOBLAST LTD MESO

NasdaqLarge CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #2,637 of 2,925

Why it scores 25Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$120.25M

Quarter to Jun 30

Net income

$-57.50M

Quarter to Jun 30

Free cash flow

$-44.66M

Quarter to Jun 30

Operating margin

-47.3%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$53.30M total
MORGAN STANLEY
$9.72M+39.7%
BlackRock, Inc.
$8.99M+5.3%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$6.19M+18.4%
GOLDMAN SACHS GROUP INC
$5.35M-0.4%
BNP Paribas Asset Management Holding S.A.
$3.51MNew
UBS Group AG
$2.71M+50.9%
SRS Capital Advisors, Inc.
$2.27M+587.9%
BANK OF AMERICA CORP /DE/
$1.35M0.0%
Penbrook Management LLC
$1.18M0.0%
Fi3 FINANCIAL ADVISORS, LLC
$1.02M-81.2%
M&G Plc
$827.4K0.0%
Quadrature Capital Ltd
$718.8K+208.0%
LPL Financial LLC
$647.6K-3.5%
LAZARI CAPITAL MANAGEMENT, INC.
$641.6K+2.8%
Rialto Wealth Management, LLC
$629.1K0.0%
GROUP ONE TRADING, L.P.
$595.7K-47.5%
ROYAL BANK OF CANADA
$595.0K+67.5%
TWO SIGMA INVESTMENTS, LP
$587.2K+9.0%
GEODE CAPITAL MANAGEMENT, LLC
$456.6K0.0%
JANE STREET GROUP, LLC
$448.5K-66.4%
WILEY BROS.-AINTREE CAPITAL, LLC
$373.0K+2.3%
CITIGROUP INC
$354.9K-0.9%
AQR CAPITAL MANAGEMENT LLC
$341.3K-0.5%
XTX Topco Ltd
$337.7K-39.0%
WELLS FARGO & COMPANY/MN
$258.3K+5.5%
See all 72 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2026
EDGAR

Net Income

FY 2026
EDGAR

EPS (Diluted)

FY 2026
EDGAR

Operating Margin

FY 2026
EDGAR

ROIC

FY 2026
EDGAR

Free Cash Flow

FY 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/MESO

Earnings Per Share

13fpro.ai/company/MESO

Loading ratio trend…

MESO key financials by period

Reported revenue, net income and operating margin by fiscal year, from MESOBLAST LTD's annual filings on SEC EDGAR.

MESOBLAST LTD reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$120.3M$-57.5M-47.3%
FY 2025$17.2M$-102.1M—
FY 2024$5.9M$-88.0M—
FY 2023$7.5M$-81.9M—
FY 2022$10.2M$-91.3M—
FY 2021$7.4M$-98.8M—
Source: MESO filings on SEC EDGAR →

Companies similar to MESO

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

MESO insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MESOBLAST LTD (MESO): stock profile, AI score and financials

MESOBLAST LTD (MESO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MESO at 25.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,637 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2026), MESOBLAST LTD reports quarterly revenue of $120.3M, net income of $-57.5M, an operating margin of -47.3%. Top institutional holders of MESO by reported 13-F value include MORGAN STANLEY, BlackRock, SUSQUEHANNA INTERNATIONAL GROUP, LLP, based on the most recent SEC filings. MESO trades on the Nasdaq exchange and files with the SEC under CIK 1345099. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MESO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MESOBLAST LTD directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1345099 →